Pharma S&M Analytics - Tata Consultancy Services
Pharma S&M Analytics - Tata Consultancy Services
Pharma S&M Analytics - Tata Consultancy Services
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Possible Strategies<br />
Some possible strategies to comply with current prevailing regulatory environment from an Sales & Marketing<br />
perspective are listed in this section. An unbiased approach in terms of communication, education to physicians to<br />
improve prescribing habits and in turn patient outcomes are based on:<br />
• Appropriate and right communication to right customers.<br />
• Evaluating type, ways and means of communication.<br />
• Validation of communication.<br />
Promotional activities with focus on providing optimal cost effective treatments are based on:<br />
• Physician-patient interests<br />
• Meaningful and effective communication that can balance the business and customer benefits.<br />
• Third-party financial arrangements should incentivize compliance all along the supply chain.<br />
Focus on pharmacovigilaince and drug safety activities that have tremendous impact on entire product life cycle<br />
(PLC) are based on:<br />
• Tracking adverse effects and untoward side effects for the marketed product in a proper form or method.<br />
• Post market surveillance studies<br />
Changing Customer - Market Dynamics<br />
<strong>Pharma</strong>ceutical industry is witnessing one of the greatest transformations in terms of customer–market dynamics.<br />
Not only the key changes like emergence of specialty and super specialty segments, increased regulatory<br />
constraints, focus on sub groups in various therapy areas and information explosion in recent times have made the<br />
situation complex, but also complicated for the pharmaceutical companies to have a right and meaningful market<br />
strategy that can address customers in an appropriate way.<br />
Past Scenario in Customer-Market Dynamics<br />
• Majority of doctors were general practitioners and physicians<br />
• Specialty medicine and super specialty were at the verge of emergence<br />
• Needs, wants and expectations were not given importance in company’s expectations<br />
• Products had clear cut benefits over predecessors<br />
• Scientific data was simple, understandable and easily interpretable<br />
• Manageable R&D costs and less burden on Sales & Marketing teams<br />
• Congenial and flexible regulatory environment with very less specifications and norms<br />
• Less legal and insurance hassles<br />
Current and Emerging Scenario in Customer-Market Dynamics<br />
• Emergence of sub-groups as important areas of focus<br />
• Specialty and super specialty segments<br />
• Emergence of physicians as ‘valued partners’<br />
• Patient as a focal point<br />
• Direct to consumer marketing<br />
• Healthcare network<br />
• Personalized medicine<br />
• Rising R&D costs<br />
• Increased medical and regulatory constraints<br />
• More legal and insurance hassles<br />
Changing Scenario in Sales and Marketing of <strong>Pharma</strong>ceutical Industry: Role of IT<br />
8